標(biāo)題: Titlebook: Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2; A Multidisciplinary Siguna Mueller Book 2023 The Editor(s) (if applicabl [打印本頁(yè)] 作者: Inoculare 時(shí)間: 2025-3-21 17:28
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2影響因子(影響力)
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2影響因子(影響力)學(xué)科排名
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2被引頻次
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2被引頻次學(xué)科排名
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2年度引用
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2年度引用學(xué)科排名
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2讀者反饋
書(shū)目名稱Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2讀者反饋學(xué)科排名
作者: ACME 時(shí)間: 2025-3-21 21:04 作者: 帶來(lái)的感覺(jué) 時(shí)間: 2025-3-22 01:25
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2978-3-031-18903-6作者: Magnitude 時(shí)間: 2025-3-22 07:53
Siguna MuellerAnalyzes the the risks and benefits of mass vaccination with mRNA vaccines.Covers the most recent scientific data on Covid-19 mRNA vaccines.Offers a broad multidisciplinary look at mRNA vaccines作者: 妨礙議事 時(shí)間: 2025-3-22 08:58 作者: intertwine 時(shí)間: 2025-3-22 14:54 作者: intertwine 時(shí)間: 2025-3-22 17:53 作者: 群居動(dòng)物 時(shí)間: 2025-3-22 23:34 作者: Schlemms-Canal 時(shí)間: 2025-3-23 01:22
Grundlagen der empirischen Untersuchung,ectiveness. Although this is a well-known problem in general, there is no easy solution. Even if one can spend 10 or 15 years assessing a new medical intervention, the problem is still difficult. People respond differently, often expose unexpected biological mechanisms triggered by the intervention,作者: 情愛(ài) 時(shí)間: 2025-3-23 06:23
https://doi.org/10.1057/9781403919618alth (PH) officials and decision bodies keep asserting that these vaccines are safe. To those who have experienced adverse events (AEs), or who have close friends or family members who got injured or even passed post-vaccination, this seems incomprehensible. After all, it should be easy to prove tha作者: Monolithic 時(shí)間: 2025-3-23 13:43
https://doi.org/10.1057/9781403919618onventional vaccines: (1) are preparations that have been made in order to meet the host immune system at a certain site of encounter (injection site); (2) involve a certain amount and type of immunologic agents; and (3) result in stimulation of immune responses to turn on immunologic memory. Accord作者: Perineum 時(shí)間: 2025-3-23 16:09 作者: Digitalis 時(shí)間: 2025-3-23 21:40 作者: Indict 時(shí)間: 2025-3-24 01:53 作者: TAG 時(shí)間: 2025-3-24 05:47 作者: dainty 時(shí)間: 2025-3-24 06:36
Appraisal of Some of the Key Postulates Underlying mRNA Vaccines, they were most influential in their fast approval, and they shaped decision making and public understanding. Many of them have been widely broadcasted by mainstream media and give the impression of being rooted in clear and detailed modeling, a sound comprehension of underlying biological mechanisms, and supported by clinical experience.作者: 孤獨(dú)無(wú)助 時(shí)間: 2025-3-24 13:56
Omicrone of the Covid-19 pandemic in a unique way. Since its emergence during the fall of 2021, it has rapidly spread worldwide and, along with its later subvariants, has soon become responsible for virtually all Covid-19 cases.作者: 喪失 時(shí)間: 2025-3-24 18:19
https://doi.org/10.1007/978-3-031-18903-6Vaccines; RNA Vaccines; COVID19; mRNA Vaccines; Public Health; Pharmacovigilance; SARS-CoV-2; Corona Virus; 作者: conifer 時(shí)間: 2025-3-24 22:06
978-3-031-18905-0The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 較早 時(shí)間: 2025-3-25 00:33
Charakterisierung des Austauschgegenstandes,This chapter describes how the above unsubstantiated assumptions underlying mRNA vaccines may impact vaccine safety. Again, the analysis here is done in a more general way, aiming to uncover mechanisms and consequences which previously do not seem to have been anticipated.作者: 出處 時(shí)間: 2025-3-25 04:53 作者: BILL 時(shí)間: 2025-3-25 10:42
https://doi.org/10.1057/9781403919618Arguably, mRNA vaccines have led to risks and concerns that previously were not anticipated. Both the vaccine by Pfizer and that by Moderna are now linked to post-vaccination deaths and many adverse health effects作者: facilitate 時(shí)間: 2025-3-25 11:40 作者: 柔聲地說(shuō) 時(shí)間: 2025-3-25 16:39
Relevance for mRNA Vaccine SafetyThis chapter describes how the above unsubstantiated assumptions underlying mRNA vaccines may impact vaccine safety. Again, the analysis here is done in a more general way, aiming to uncover mechanisms and consequences which previously do not seem to have been anticipated.作者: intimate 時(shí)間: 2025-3-25 22:21
Safeguarding Against the Analog of Antimicrobial-Resistance DevelopmentThis section aims to point to perhaps one of the greatest challenges of all current Covid-19 vaccines altogether. Just as in the previous section, it does not apply to mRNA vaccines alone, although special focus will be given to the latter whenever possible.作者: GRIEF 時(shí)間: 2025-3-26 03:57
Scales, Pseudoscales, the Human Factor, and a Way ForwardArguably, mRNA vaccines have led to risks and concerns that previously were not anticipated. Both the vaccine by Pfizer and that by Moderna are now linked to post-vaccination deaths and many adverse health effects作者: 審問(wèn) 時(shí)間: 2025-3-26 08:09 作者: 瘋狂 時(shí)間: 2025-3-26 12:17 作者: commute 時(shí)間: 2025-3-26 13:09 作者: 預(yù)兆好 時(shí)間: 2025-3-26 20:50
https://doi.org/10.1057/9780230251090e of the Covid-19 pandemic in a unique way. Since its emergence during the fall of 2021, it has rapidly spread worldwide and, along with its later subvariants, has soon become responsible for virtually all Covid-19 cases.作者: artifice 時(shí)間: 2025-3-27 00:12
Book 2023irst?books to give a comprehensive overview of mRNA vaccines against?COVID-19 and the?only one that addresses this topic from a broad multidisciplinary?background.?It brings together insights?from?various underlying disciplines on the challenges of developing and evaluating the most suitable vaccine作者: airborne 時(shí)間: 2025-3-27 02:46
From Challenges to Opportunities and Open Questionsthose most vulnerable, (b) that they are acknowledged as products whose underpinnings and biological actions remain incompletely known, and (c) that it is critical to continually assess their weaknesses and strengths and work toward updates and improvements.作者: collateral 時(shí)間: 2025-3-27 06:00
mRNA Covid-19 Vaccines Best Reflect Effective Pharmaceuticals—Basic Considerations and LNPsingly, conventional vaccines contain weakened/killed forms of the microorganism or an inactivated form of the toxin, usually complemented by some adjuvants. Importantly, the evoked immune response is to the injected material, i.e., to something that is limited and essentially fixed.作者: TAG 時(shí)間: 2025-3-27 09:37
Book 2023s for?mass vaccination programs enrolled?throughout?the world - focusing on safety and efficacy...This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher?interested?in SARS-CoV2 or virology and vaccine development in general.?.作者: 盤(pán)旋 時(shí)間: 2025-3-27 14:34 作者: braggadocio 時(shí)間: 2025-3-27 20:00 作者: 專橫 時(shí)間: 2025-3-27 23:46
Offers a broad multidisciplinary look at mRNA vaccines.This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first?books to give a comprehensive overview of mRNA vaccines against?COVID-19 and the?only one t作者: Hectic 時(shí)間: 2025-3-28 05:53 作者: locus-ceruleus 時(shí)間: 2025-3-28 09:45 作者: Hemoptysis 時(shí)間: 2025-3-28 13:15 作者: 天空 時(shí)間: 2025-3-28 16:53 作者: 頭盔 時(shí)間: 2025-3-28 22:49
The Challenge of Evaluating Vaccine Safety and Effectivenessintervention, the problem is still difficult. People respond differently, often expose unexpected biological mechanisms triggered by the intervention, with some of them manifesting immediately, while others taking much longer to be seen.作者: PLAYS 時(shí)間: 2025-3-29 00:36
mRNA Vaccine Safety and Efficacy—Official Criteria When AEs Are Caused by the Injectionlose friends or family members who got injured or even passed post-vaccination, this seems incomprehensible. After all, it should be easy to prove that someone died or become severely injured from a medical intervention, one might think.作者: epicardium 時(shí)間: 2025-3-29 04:18
Other Facets of SARS-CoV-2 Immunity, the Risk of Immune Tolerance and T Cell Exhaustionfactor indicating protection. However, as seen from the course of the pandemic, antibody levels alone are not sufficient to prevent infection (Chap. .). This has become increasingly obvious during the Omicron wave(s), demonstrating “how fragile antibody-based immunity can be in the face of a changing virus.”作者: 蔑視 時(shí)間: 2025-3-29 08:41
Conclusionone knows that. Despite the unprecedented seriousness of the situation, this book has gathered significant evidence that suggests that the emergency approval of the first Covid-19 vaccines was premature.作者: 卵石 時(shí)間: 2025-3-29 11:32 作者: Culmination 時(shí)間: 2025-3-29 19:11 作者: 行為 時(shí)間: 2025-3-29 22:24
From Challenges to Opportunities and Open Questionsine takes about 10–15 years. To combat the pandemic, all current Covid vaccines were developed and tested in record-breaking time and approved for “emergency use authorization.” It is important to keep this in mind, with the understanding that (a) their rapid rollout was deemed necessary to protect 作者: Desert 時(shí)間: 2025-3-30 00:44
The Challenge of Evaluating Vaccine Safety and Effectivenessectiveness. Although this is a well-known problem in general, there is no easy solution. Even if one can spend 10 or 15 years assessing a new medical intervention, the problem is still difficult. People respond differently, often expose unexpected biological mechanisms triggered by the intervention,作者: Aggregate 時(shí)間: 2025-3-30 06:10
mRNA Vaccine Safety and Efficacy—Official Criteria When AEs Are Caused by the Injectionalth (PH) officials and decision bodies keep asserting that these vaccines are safe. To those who have experienced adverse events (AEs), or who have close friends or family members who got injured or even passed post-vaccination, this seems incomprehensible. After all, it should be easy to prove tha作者: STYX 時(shí)間: 2025-3-30 09:24
mRNA Covid-19 Vaccines Best Reflect Effective Pharmaceuticals—Basic Considerations and LNPsonventional vaccines: (1) are preparations that have been made in order to meet the host immune system at a certain site of encounter (injection site); (2) involve a certain amount and type of immunologic agents; and (3) result in stimulation of immune responses to turn on immunologic memory. Accord作者: CAND 時(shí)間: 2025-3-30 14:11
Other Facets of SARS-CoV-2 Immunity, the Risk of Immune Tolerance and T Cell Exhaustionlen the limelight.” Especially during the first two years of the pandemic, the level of “neutralizing antibodies” was believed to be the main and key factor indicating protection. However, as seen from the course of the pandemic, antibody levels alone are not sufficient to prevent infection (Chap. .作者: beta-cells 時(shí)間: 2025-3-30 18:00 作者: 壓倒性勝利 時(shí)間: 2025-3-30 23:34 作者: 掃興 時(shí)間: 2025-3-31 02:21
